文献速递贫血与红细胞疾病

转铁蛋白受体1通过微调肝细胞铁负荷调控铁调素表达以维持全身铁稳态

Transferrin receptor 1 controls systemic iron homeostasis by fine-tuning hepcidin expression to hepatocellular iron load.
PubMed 文献 · Blood · 2018-12-11

研究通过构建肝细胞特异性敲除转铁蛋白受体1(Tfr1)的小鼠模型,发现TfrcAlb-Cre小鼠肝脏铁含量降低,但肝Hamp mRNA和血清铁调素水平与对照无差异,Hamp/肝铁含量比值显著升高,伴随轻度低铁血症和微细胞增多,并易患缺铁性贫血。结论:Tfr1对基础肝细胞铁供应冗余,但对根据肝细胞铁负荷微调铁调素反应至关重要,且可能通过Hfe抑制铁信号。

要点

  • 肝细胞特异性Tfr1敲除小鼠可存活且无肝病理,但肝铁含量低于对照。
  • TfrcAlb-Cre小鼠Hamp/肝铁含量比值显著高于对照,伴轻度低铁血症和微细胞增多。
  • Tfr1对基础肝细胞铁供应冗余,但对铁调素微调至关重要

核心结论

  • Tfr1对基础肝细胞铁供应冗余,但对根据肝细胞铁负荷微调铁调素反应至关重要。
  • 数据提示Tfr1通过其与Hfe的相互作用抑制铁信号至铁调素,并连接细胞与全身铁调控通路。

研究设计与样本

  • 研究生成肝细胞特异性Tfr1敲除(TfrcAlb-Cre)小鼠,与对照Tfrcfl/fl同窝小鼠比较。
  • 通过检测肝铁含量、Hamp mRNA、血清铁调素、饮食铁干预及全转铁蛋白注射等实验评估铁稳态。

主要发现

  • TfrcAlb-Cre小鼠肝脏铁含量低于对照Tfrcfl/fl同窝小鼠,因Tfr1缺陷肝细胞从转铁蛋白内化铁能力降低。
  • TfrcAlb-Cre与Tfrcfl/fl小鼠肝Hamp mRNA和血清铁调素水平无差异,但前者Hamp/肝铁含量和铁调素/肝铁含量比值显著更高。
  • TfrcAlb-Cre小鼠出现轻度低铁血症和微细胞增多,易患缺铁性贫血。
  • TfrcAlb-Cre小鼠在饮食铁干预或全转铁蛋白注射后能适当调节Hamp表达;原代TfrcAlb-Cre肝细胞中全转铁蛋白可正常诱导Hamp mRNA、铁蛋白和Tfr2。
  • 原代TfrcAlb-Cre肝细胞可从59Fe-转铁蛋白获取59Fe,推测通过Tfr2。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Transferrin receptor 1 (Tfr1) mediates uptake of circulating transferrin-bound iron to developing erythroid cells and other cell types. Its critical physiological function is highlighted by the embryonic lethal phenotype of Tfr1-knockout (Tfrc-/-) mice and the pathologies of several tissue-specific knockouts. We generated TfrcAlb-Cre mice bearing hepatocyte-specific ablation of Tfr1 to explore implications in hepatocellular and systemic iron homeostasis. TfrcAlb-Cre mice are viable and do not display any apparent liver pathology. Nevertheless, their liver iron content (LIC) is lower compared with that of control Tfrcfl/fl littermates as a result of the reduced capacity of Tfr1-deficient hepatocytes to internalize iron from transferrin. Even though liver Hamp messenger RNA (mRNA) and serum hepcidin levels do not differ between TfrcAlb-Cre and Tfrcfl/fl mice, Hamp/LIC and hepcidin/LIC ratios are significantly higher in the former. Importantly, this is accompanied by modest hypoferremia and microcytosis, and it predisposes TfrcAlb-Cre mice to iron-deficiency anemia. TfrcAlb-Cre mice appropriately regulate Hamp expression following dietary iron manipulations or holo-transferrin injection. Holo-transferrin also triggers proper induction of Hamp mRNA, ferritin, and Tfr2 in primary TfrcAlb-Cre hepatocytes. We further show that these cells can acquire 59Fe from 59Fe-transferrin, presumably via Tfr2. We conclude that Tfr1 is redundant for basal hepatocellular iron supply but essential for fine-tuning hepcidin responses according to the iron load of hepatocytes. Our data are consistent with an inhibitory function of Tfr1 on iron signaling to hepcidin via its interaction with Hfe. Moreover, they highlight hepatocellular Tfr1 as a link between cellular and systemic iron-regulatory pathways.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Fillebeen C, Charlebois E, Wagner J, et al. Transferrin receptor 1 controls systemic iron homeostasis by fine-tuning hepcidin expression to hepatocellular iron load. Blood. 2018. PMID: 30538134. doi:10.1182/blood-2018-05-850404

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。